Krystal Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	496.3	344.87	358.33	161.9	341.25
Short-Term Investments	331.49	252.65	173.85	217.27	96.85
Cash & Short-Term Investments	827.79	597.52	532.18	379.17	438.1
Cash Growth	38.54%	12.28%	40.35%	-13.45%	61.50%
Receivables	127.43	104.75	42.04	-	-
Inventory	40.48	26.51	6.99	-	-
Prepaid Expenses	28.91	13.27	6.71	4.61	4.17
Total Current Assets	1,025	742.05	587.91	383.78	442.27
Property, Plant & Equipment	158.02	161.45	168.23	169.73	119.58
Long-Term Investments	128.07	152.11	61.95	4.62	64.37
Long-Term Deferred Tax Assets	22.82	-	-	-	-
Other Long-Term Assets	0.29	0.23	0.26	0.32	0.07
Total Assets	1,334	1,056	818.36	558.45	626.3
Accounts Payable	3.24	4.99	4.13	3.98	8.4
Accrued Expenses	81.25	52.78	18.15	11.54	6.52
Current Portion of Leases	1.77	1.22	1.47	1.56	1.04
Current Income Taxes Payable	10.92	4.29	1.96	0.04	0.08
Other Current Liabilities	5.77	38.73	7.38	11.72	9.69
Total Current Liabilities	102.94	102	33.09	28.85	25.74
Long-Term Leases	7.57	6.04	6.62	7.37	6.98
Other Long-Term Liabilities	3.72	1.42	-	-	-
Total Liabilities	114.23	109.46	39.71	36.22	32.72
Additional Paid-In Capital	1,194	1,127	1,048	803.72	734.52
Retained Earnings	24.16	-180.67	-269.83	-280.76	-140.78
Comprehensive Income & Other	1.14	-0.19	0.64	-0.73	-0.16
Total Common Equity	1,220	946.38	778.64	522.23	593.58
Shareholders' Equity	1,220	946.38	778.64	522.23	593.58
Total Liabilities & Equity	1,334	1,056	818.36	558.45	626.3
Total Debt	9.34	7.26	8.09	8.93	8.02
Net Cash (Debt)	946.52	742.37	586.04	374.86	494.44
Net Cash Growth	27.50%	26.68%	56.34%	-24.19%	84.97%
Net Cash Per Share	31.60	24.96	21.12	14.70	22.28
Filing Date Shares Outstanding	29.23	28.81	28.29	25.76	25.21
Total Common Shares Outstanding	29.19	28.79	28.24	25.76	25.21
Working Capital	921.66	640.05	554.82	354.93	416.53
Book Value Per Share	41.78	32.87	27.58	20.27	23.55
Tangible Book Value	1,220	946.38	778.64	522.23	593.58
Tangible Book Value Per Share	41.78	32.87	27.58	20.27	23.55
Buildings	109.24	111.44	111.18	-	-
Machinery	37.48	34.19	30.49	12.93	6.51
Construction In Progress	8.11	5.78	7.29	131.33	104.34
Leasehold Improvements	27.23	25.67	25.07	24.22	5.72

Updated Feb 17, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q